Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Influenza Congress USA

12 Nov 2012 - 13 Nov 2012 - Washington DC, USA



Bookmark and Share


Innovation and opportunity for pharma, biotech, healthcare and investors 

The 4th annual Influenza Congress USA is where key decision makers from pharma, biotech and government come together to plan their development strategies and share best practice with their peers in ‘flu vaccine manufacturing.

Last year, we had senior executives from GSK, Novartis, Sanofi Pasteur, CSL and over 100 other companies discussing adjuvant approval in the US, universal vaccine development, cell-based vaccine development, biotech partnering and funding, delivery, experimental challenge studies and novel egg-based vaccine manufacturing.

Come to Influenza Congress USA and learn:


· How to grow business in light of current developments – H5N1, adjuvant approval, 

cell-based vaccine commercialization, low volume manufacturing

· How to navigate regulatory compliance

· How to fast track FDA approval

· How to monetize new discoveries sooner

· How to eliminate research and manufacturing bottlenecks

· How to attract investment and funding

· How to choose partners

· How to identify the most cost-effective technologies


Can you afford not to be here?


For more information contact, please visit our website, www.terrapinn.com/influenza, or call +1 212 379 6320.



Further information
Scientific News
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!